Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Large Insider Purchases

Institutional-Scale SEC Form 4 Buy Signals

The Signal of $1M+ Conviction

When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.

Filing Date Trade Date Ticker Company Name Reporting Person Relationship Industry Type Price Qty Total, $ Owned After Change, %
2016-03-18 23:30 2016-03-18 TSRO N/A ORONSKY ARNOLD L Director Other BUY $35.19 142,085 $4,999,971 2,013,786 +7.6%
2016-03-18 23:30 2016-03-18 TSRO N/A SEIDENBERG BETH C Director Other BUY $35.19 1,420,858 $49,999,993 227,255 +100.0%
2016-03-19 01:01 2016-03-16 CAPR CAPRICOR THERAPEUTICS, INC. St. John Edward A. 10% owner Pharmaceutical Preparations BUY $2.40 833,332 $1,999,997 842,439 +9,150.5%
2016-03-19 02:22 2016-03-16 CARA Tvardi Therapeutics, Inc. RHO Ventures VI LP 10% owner Pharmaceutical Preparations BUY $4.87 400,000 $1,949,200 3,068,057 +15.0%
2016-03-19 00:37 2016-03-18 TSRO N/A BARRIS PETER J 10% owner Other BUY $35.19 1,420,858 $49,999,993 710,429 +100.0%
2016-03-17 23:05 2016-03-15 COCP Cocrystal Pharma, Inc. Schinazi Raymond F Director, 10% owner Pharmaceutical Preparations BUY $0.51 2,941,176 $1,500,000 275,520,853 +1.1%
2016-03-17 23:05 2016-03-15 COCP Cocrystal Pharma, Inc. FROST PHILLIP MD ET AL Director, 10% owner Pharmaceutical Preparations BUY $0.51 2,941,177 $1,500,000 106,500,147 +2.8%
2016-03-18 00:15 2016-03-15 SRG Seritage Growth Properties BERKOWITZ BRUCE R 10% owner Real Estate BUY $43.55 30,000 $1,306,401 3,426,850 +0.9%
2016-03-17 20:12 2016-03-11 FNBG N/A ATWOOD THOMAS G Director, 10% owner Other BUY $29.31 154,764 $4,536,133 120,554 +100.0%
2016-03-18 02:14 2016-03-15 INCY INCYTE CORP BAKER JULIAN Director, 10% owner Services-Commercial Physical & Biological Research BUY $63.98 800,000 $51,184,160 19,757,285 +4.2%
2016-03-18 01:08 2016-03-15 STMP N/A JONES G BRADFORD Director Other BUY $113.15 10,000 $1,131,500 57,286 +21.1%
2016-03-18 03:18 2016-03-16 ABTL N/A CARPENTER MICHAEL A Director Other BUY $18,248.00 5,000 $91,240,000 10,000 +100.0%
2016-03-17 22:08 2016-03-15 ESNT Essent Group Ltd. PBRA (CAYMAN) Co 10% owner, Other Surety Insurance BUY $19.56 265,017 $5,184,342 10,708,652 +2.5%
2016-03-16 17:38 2015-12-15 RCIAX N/A Resource Financial Fund Management, Inc. Other Other BUY $9.82 152,749 $1,500,000 152,749 +100.0%
2016-03-17 03:09 2016-03-14 SRPT Sarepta Therapeutics, Inc. Barry Richard Director Pharmaceutical Preparations BUY $15.66 75,000 $1,174,185 3,241,014 +2.4%
2016-03-16 23:14 2016-03-14 WES N/A ANADARKO PETROLEUM CORP 10% owner Other BUY $29.91 2,089,602 $62,499,996 52,143,426 +4.2%
2016-03-17 00:17 2016-03-14 ITRI ITRON, INC. SCOPIA CAPITAL MANAGEMENT LP 10% owner Instruments For Meas & Testing of Electricity & Elec Signals BUY $41.94 82,234 $3,448,845 4,475,083 +1.9%
2016-03-17 03:15 2016-03-14 SRPT Sarepta Therapeutics, Inc. BEHRENS M KATHLEEN Director Pharmaceutical Preparations BUY $16.28 75,000 $1,220,708 21,855 +100.0%
2016-03-17 01:56 2016-03-15 AQXP Neurogene Inc. BAKER BROS. ADVISORS LP 10% owner Pharmaceutical Preparations BUY $7.99 471,667 $3,770,647 6,928,119 +7.3%
2016-03-17 01:57 2016-03-14 SGEN N/A BAKER FELIX Director, 10% owner Other BUY $32.10 1,349,237 $43,311,992 38,671,506 +3.6%
2016-03-16 23:48 2016-03-14 FLML AVADEL PHARMACEUTICALS PLC STAPLETON CRAIG R Director Pharmaceutical Preparations BUY $10.39 100,000 $1,039,400 482,450 +26.1%
2016-03-15 16:00 2016-03-11 OVAS Tempest Therapeutics, Inc. Dipp Michelle Director, Officer - Chief Executive Officer Pharmaceutical Preparations BUY $7.60 162,732 $1,237,089 162,732 +100.0%
2016-03-16 01:17 2016-03-11 SMLP N/A ENERGY CAPITAL PARTNERS II, LLC Director, 10% owner Other BUY $14.88 319,293 $4,751,623 4,569,089 +7.5%
2016-03-15 23:38 2016-03-11 PSG N/A Sagard Capital Partners, L.P. 10% owner Other BUY $3.96 651,400 $2,580,391 6,862,688 +10.5%
2016-03-16 00:57 2016-03-11 EDGE PDS Biotechnology Corp HEALY JAMES Director Pharmaceutical Preparations BUY $7.30 541,343 $3,951,641 2,852,711 +23.4%
2016-03-15 23:09 2016-03-11 TPX SOMNIGROUP INTERNATIONAL INC. THOMPSON SCOTT L Director, Officer - CEO & PRESIDENT Household Furniture BUY $57.67 35,000 $2,018,394 104,686 +50.2%
2016-03-15 16:01 2016-03-11 OVAS Tempest Therapeutics, Inc. ALDRICH RICHARD Director Pharmaceutical Preparations BUY $7.60 162,732 $1,237,089 162,732 +100.0%
2016-03-15 23:31 2016-03-14 TBPH Theravance Biopharma, Inc. GLAXOSMITHKLINE PLC 10% owner Pharmaceutical Preparations BUY $23,027,965.50 1,301,015 $29,959,728,534,983 9,644,807 +15.6%
2016-03-14 23:44 2016-03-10 ECL ECOLAB INC. GATES WILLIAM H III 10% owner Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics BUY $105.36 499,999 $52,678,795 28,420,393 +1.8%
2016-03-11 23:28 2016-03-09 CNA CNA FINANCIAL CORP LOEWS CORP 10% owner Fire, Marine & Casualty Insurance BUY $30.20 105,100 $3,174,377 242,649,773 +0.0%
2016-03-12 02:49 2016-03-07 IEEC N/A Kiles James Jacob Officer - CEO & President Other BUY $15,000.00 6,000,000 $90,000,000,000 6,000,000 +100.0%
2016-03-12 00:35 2016-03-09 GI N/A Kaufman David L Director Other BUY $4.64 227,700 $1,057,006 1,998,759 +12.9%
2016-03-12 02:37 2016-03-09 ITRI ITRON, INC. SCOPIA CAPITAL MANAGEMENT LP 10% owner Instruments For Meas & Testing of Electricity & Elec Signals BUY $42.04 53,267 $2,239,393 4,392,849 +1.2%
2016-03-12 02:13 2016-03-09 SGEN N/A BAKER FELIX Director, 10% owner Other BUY $32.46 694,666 $22,551,290 37,454,776 +1.9%
2016-03-12 01:21 2016-03-10 ESNT Essent Group Ltd. PBRA (CAYMAN) Co 10% owner, Other Surety Insurance BUY $19.50 143,097 $2,790,592 10,443,635 +1.4%
2016-03-10 23:52 2016-03-09 N-A Crescent Capital BDC, Inc. UFCW-Northern California Employers Joint Pension Plan 10% owner Other BUY $19.22 2,765,987 $53,159,508 1,075,372 +100.0%
2016-03-11 05:27 2016-03-08 SMLP N/A ENERGY CAPITAL PARTNERS II, LLC Director, 10% owner Other BUY $14.96 361,871 $5,412,866 4,249,796 +9.3%
2016-03-11 00:24 2016-03-09 N-A Crescent Capital BDC, Inc. Allied World Assurance Co Holdings, AG 10% owner Other BUY $19.22 221,832 $4,263,382 1,662,947 +15.4%
2016-03-11 00:38 2016-03-08 ESNT Essent Group Ltd. PBRA (CAYMAN) Co 10% owner, Other Surety Insurance BUY $19.42 289,838 $5,628,857 10,300,538 +2.9%
2016-03-11 05:25 2016-03-08 LORL N/A RACHESKY MARK H MD Director, 10% owner Other BUY $35.70 190,000 $6,783,000 1,211,467 +18.6%
2016-03-09 20:39 2016-03-09 N-A Crescent Capital BDC, Inc. Fidelity & Guaranty Life 10% owner Other BUY $19.22 221,832 $4,263,382 1,662,947 +15.4%
2016-03-10 01:06 2016-03-07 APPF Appfolio Inc. STAD MARC 10% owner Services-Prepackaged Software BUY $11.83 109,094 $1,291,007 1,646,066 +7.1%
2016-03-10 00:30 2016-02-26 GLYE N/A WYNNEFIELD PARTNERS SMALL CAP VALUE LP 10% owner Other BUY $0.08 18,750,001 $1,500,000 15,261,361 +100.0%
2016-03-09 01:22 2016-03-04 AGR N/A Galan Ignacio Sanchez Director Other BUY $38.47 100,000 $3,846,700 100,000 +100.0%
2016-03-09 02:01 2016-03-04 ITRI ITRON, INC. SCOPIA CAPITAL MANAGEMENT LP 10% owner Instruments For Meas & Testing of Electricity & Elec Signals BUY $41.45 52,328 $2,169,027 4,339,582 +1.2%
2016-03-08 22:34 2016-03-04 ERC ALLSPRING MULTI-SECTOR INCOME FUND Saba Capital Management, L.P. 10% owner Other BUY $11.67 93,457 $1,090,718 5,207,565 +1.8%
2016-03-09 01:43 2016-03-04 CBAK CBAK Energy Technology, Inc. Li Yunfei Director, Officer, 10% owner - CHIEF EXECUTIVE OFFICER Miscellaneous Electrical Machinery, Equipment & Supplies BUY $2.40 3,000,000 $7,200,000 3,030,000 +10,000.0%
2016-03-09 01:04 2016-03-04 SGEN N/A BAKER FELIX Director, 10% owner Other BUY $22.66 502,523 $11,386,719 36,830,268 +1.4%
2016-03-09 02:38 2016-03-08 SNDX Syndax Pharmaceuticals Inc ROYSTON IVOR Director Pharmaceutical Preparations BUY $12.00 150,000 $1,800,000 750,545 +25.0%
2016-03-08 05:24 2016-03-03 SMLP N/A ENERGY CAPITAL PARTNERS II, LLC Director, 10% owner Other BUY $14.36 601,363 $8,634,370 3,887,925 +18.3%
SHOW ENTRIES

Institutional Conviction in Form 4

Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.

Filtering the Market Noise

Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.